ArticleDisease markers2016

Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.

Massimiliano Castellazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.